176 related articles for article (PubMed ID: 12713866)
21. Simvastatin and lovastatin inhibit breast cell invasion induced by H-Ras.
Kang S; Kim ES; Moon A
Oncol Rep; 2009 May; 21(5):1317-22. PubMed ID: 19360310
[TBL] [Abstract][Full Text] [Related]
22. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors.
Yang SH; Choi JS; Choi DH
Pharmacology; 2011; 88(1-2):1-9. PubMed ID: 21709429
[TBL] [Abstract][Full Text] [Related]
23. HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.
Al-Haidari AA; Syk I; Thorlacius H
Biochem Biophys Res Commun; 2014 Mar; 446(1):68-72. PubMed ID: 24582560
[TBL] [Abstract][Full Text] [Related]
24. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase.
Corsini A; Mazzotti M; Raiteri M; Soma MR; Gabbiani G; Fumagalli R; Paoletti R
Atherosclerosis; 1993 Jun; 101(1):117-25. PubMed ID: 8216498
[TBL] [Abstract][Full Text] [Related]
25. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
27. Effect of simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, on alpha-fetoprotein gene expression through interaction with the ras-mediated pathway.
Mazume H; Nakata K; Hida D; Hamasaki K; Tsuruta S; Nakao K; Kato Y; Eguchi K
J Hepatol; 1999 May; 30(5):904-10. PubMed ID: 10365819
[TBL] [Abstract][Full Text] [Related]
28. Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme A reductase, on the growth of human Ito cells.
Mallat A; Preaux AM; Blazejewski S; Dhumeaux D; Rosenbaum J; Mavier P
Hepatology; 1994 Dec; 20(6):1589-94. PubMed ID: 7982659
[TBL] [Abstract][Full Text] [Related]
29. Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway.
Vrtovsnik F; Couette S; Prié D; Lallemand D; Friedlander G
Kidney Int; 1997 Oct; 52(4):1016-27. PubMed ID: 9328940
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
[TBL] [Abstract][Full Text] [Related]
31. Action of lovastatin, simvastatin, and pravastatin on sterol synthesis and their antiproliferative effect in cultured myoblasts from human striated muscle.
van Vliet AK; Nègre-Aminou P; van Thiel GC; Bolhuis PA; Cohen LH
Biochem Pharmacol; 1996 Nov; 52(9):1387-92. PubMed ID: 8937448
[TBL] [Abstract][Full Text] [Related]
32. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of cholesterol synthesis and hepatic 3-hydroxy-3-methylglutaryl--CoA reductase in rats by simvastatin and pravastatin.
Del Puppo M; Rauli S; Galli Kienle M
Lipids; 1995 Nov; 30(11):1057-61. PubMed ID: 8569435
[TBL] [Abstract][Full Text] [Related]
34. Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells.
Grandaliano G; Biswas P; Choudhury GG; Abboud HE
Kidney Int; 1993 Sep; 44(3):503-8. PubMed ID: 8231022
[TBL] [Abstract][Full Text] [Related]
35. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells.
Bassa BV; Roh DD; Vaziri ND; Kirschenbaum MA; Kamanna VS
Biochim Biophys Acta; 1999 Mar; 1449(2):137-49. PubMed ID: 10082972
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
37. Modulation of COX-2 expression by statins in human monocytic cells.
Habib A; Shamseddeen I; Nasrallah MS; Antoun TA; Nemer G; Bertoglio J; Badreddine R; Badr KF
FASEB J; 2007 Jun; 21(8):1665-74. PubMed ID: 17317725
[TBL] [Abstract][Full Text] [Related]
38. Simvastatin inhibits protein isoprenylation in the brain.
Ostrowski SM; Johnson K; Siefert M; Shank S; Sironi L; Wolozin B; Landreth GE; Ziady AG
Neuroscience; 2016 Aug; 329():264-74. PubMed ID: 27180285
[TBL] [Abstract][Full Text] [Related]
39. Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Corsini A; Bernini F; Quarato P; Donetti E; Bellosta S; Fumagalli R; Paoletti R; Soma VM
Cardiology; 1996; 87(6):458-68. PubMed ID: 8904671
[TBL] [Abstract][Full Text] [Related]
40. Effects of long-term administration of HMG-CoA reductase inhibitors on cholesterol synthesis in lens.
Kalinowski SS; Tanaka RD; Mosley ST
Exp Eye Res; 1991 Aug; 53(2):179-86. PubMed ID: 1915674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
